Cartiva

Cartiva is a private, venture capital-backed company that was spun out from Carticept Medical in December 2011. Cartiva is dedicated to improving the quality of life for patients with osteoarthritis or cartilage damage through the development of novel therapies. Cartiva’s mission is to develop and market products to help physicians treat osteoarthritis and cartilage injuries and the related pain more effectively.

The company's management team, the board of directors, and medical advisors are comprised of industry-recognized professionals who possess broad knowledge in orthopedics and extensive experience managing innovative medical devices from development through clinical trials, FDA approval, and successful commercialization.

Cartiva is located in Alpharetta, Georgia.

Cartiva headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Wellness, Medical Device sector. The company focuses on Biotechnology and has secured $3.6B in funding across 120 round(s). With a team of 11-50 employees, Cartiva is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Cartiva, raised $4.3M. Discover more about their projects, partnerships, and impact on our platform.